Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest ischemic stroke Stories

2010-10-08 06:00:00

MOUNTAIN VIEW, Calif., Oct. 8 /PRNewswire/ -- Concentric Medical, Inc. today announced the full European launch of Trevo(TM), the first device utilizing Stentriever(TM) technology for clot retrieval in ischemic stroke patients. Trevo is the newest offering in a portfolio of products from Concentric Medical, the company that first introduced retrievers for acute ischemic stroke. The Trevo's stent-like design leverages the company's long history of developing clot retrieval technologies for...

2010-10-04 06:00:00

MOUNTAIN VIEW, Calif., Oct. 4 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that the Merci Retriever® has recently received both product and procedure reimbursement from the Japanese Ministry of Health, Labor and Welfare. The Merci Retriever is a catheter-based medical device that physicians at stroke centers use to remove blood clots from the brains of patients suffering an ischemic...

2010-09-30 06:00:00

MOUNTAIN VIEW, Calif., Sept. 30 /PRNewswire/ -- Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced the start of the TREVO Study. The first patients were enrolled and successfully treated at the Hospital Clinic de Barcelona by the Neuroradiology team of Drs. Juan Macho and Jordi Blasco. The TREVO Study (Thrombectomy REvascularization of large Vessel Occlusions in acute ischemic stroke) is the first to evaluate Stentriever(TM) technology in a...

2010-07-12 07:30:00

NEW BRUNSWICK, N.J. and SAN JOSE, Calif., July 12 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) and Micrus Endovascular Corporation (Nasdaq: MEND), a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cash for stock exchange. Under the terms of the agreement, Micrus Endovascular stockholders will receive at closing $23.40 for each...

2010-06-02 06:00:00

MOUNTAIN VIEW, Calif., June 2 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced an important expanded indication for the full line of DAC(TM) Neurovascular Catheters. CE Mark was granted allowing the DAC family of distal access catheters to be used for the removal/aspiration of fresh, soft emboli and thrombi from vessels in the arterial system, including the neurovasculature. Now, the full range of DAC...

2010-05-04 05:00:00

MOUNTAIN VIEW, Calif., May 4 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that the Merci Retriever®, Merci® Microcatheter, and Merci® Balloon Guide Catheter have received Shonin approval in Japan. The Merci Retriever is a catheter-based medical device that stroke centers use to remove blood clots from the brains of patients suffering an ischemic...

2010-04-20 14:47:00

SAN DIEGO, April 20 /PRNewswire/ -- Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug (IND) for a clinical trial for ischemic stroke using Stemedica's high potency proprietary allogeneic stem cells (adult human). "The FDA acceptance of our IND application and the clinical protocol for usage of allogeneic mesenchymal bone marrow-derived stem...

2010-04-03 09:36:19

Young adults with overactive thyroid face a 44 percent increased risk of stroke compared to those with normal thyroid function, according to a study reported in Stroke: Journal of the American Heart Association. "Strokes of undetermined cause account for between one-third and one-fourth of all ischemic strokes in young people," said Herng-Ching Lin, Ph.D., senior author of the study and professor at the School of Health Care Administration, College of Medicine, Taipei Medical University in...

2010-02-26 10:46:00

Study highlights: -- The antiplatelet drug cilostazol was better than aspirin in preventing a recurrent stroke in a Japanese trial. -- Compared to patients taking aspirin, patients taking the drug were less likely to have new ischemic stroke or develop bleeding requiring hospitalization. -- Cilostazol is used to reduce leg pain associated with peripheral vascular disease in the United States. SAN ANTONIO, Feb. 26 /PRNewswire-USNewswire/ -- The antiplatelet drug cilostazol -- used in the...

2010-02-25 07:34:23

Post-menopausal women who reported consuming the most daily dietary fat had a 40 percent higher incidence of clot-caused strokes compared to women who ate the least amount, according to research presented at the American Stroke Association's International Stroke Conference 2010. The incidence of ischemic stroke also increased by 30 percent in the quartile of women consuming the highest daily amount of trans fat (average intake 7 grams per day) compared to those who consumed the least (average...